Dyne Therapeutics Inc. (DYN) announced the pricing of an underwritten public offering of about 24.24 million shares of its common stock at a public offering price of $8.25 per share. The company ...

The number of robots in Amazon facilities just surpassed one million, the most the e-commerce giant has ever had. Continue Reading View Comments ...

PROCEPT BioRobotics Corporation (NASDAQ:PRCT), listed on the NASDAQ Composite and part of the healthcare technology sector.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

The technical body of Brazilian antitrust regulator CADE recommended on Monday a decision against Apple (NASDAQ:AAPL) for what it called anti-competitive practices in the tech giant’s iOS ecosystem.

OpenAI said it has no active plans to use Google (NASDAQ:GOOGL)’s in-house chip to power its products, two days after Reuters and other news outlets reported on the AI lab’s ...

Brazilian central bank figures released on Monday show a slight rise in the public sector gross debt to 76.1 per cent of gross domestic product (GDP) in May versus 76.0 per cent in April. The modest ...

Shheikh.io, an AI-powered Web3 platform, has announced the launch of its marketplace for fractional ownership of luxury real estate and other high-value assets. The platform aims to facilitate access ...

Health care stocks rose Monday afternoon with the NYSE Health Care Index climbing 0.2% and the Healt PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold ...

Artificial intelligence circuit board 5] Jonathan Kitchen In a bid to lead the next wave of AI innovation, Meta (NASDAQ:META [ is creating a “superintelligence” division dedicated to developing ...

Microsoft has developed an artificial intelligence (AI) system that it claims is four times better than doctors at diagnosing complex illnesses. The tech company’s AI diagnosis system was able to ...

Alzheimers Concept Horizontal] travellinglight/iStock via Shares of INmune Bio (NASDAQ:INMB [ dropped on Monday after the company did not achieve the main goal in a mid-stage trial for its TNF ...